Compare CCCX & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCCX | MLTX |
|---|---|---|
| Founded | 2024 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.1M | 979.8M |
| IPO Year | 2025 | N/A |
| Metric | CCCX | MLTX |
|---|---|---|
| Price | $17.08 | $15.96 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $22.22 |
| AVG Volume (30 Days) | 1.8M | ★ 3.6M |
| Earning Date | 01-01-0001 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.03 | $5.95 |
| 52 Week High | $27.50 | $62.75 |
| Indicator | CCCX | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.01 |
| Support Level | N/A | $15.70 |
| Resistance Level | N/A | $16.86 |
| Average True Range (ATR) | 0.00 | 1.29 |
| MACD | 0.00 | 0.09 |
| Stochastic Oscillator | 0.00 | 62.14 |
Churchill Capital Corp X is a blank check company.
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.